What We See for 2023: The Pharma Advertising Trends Taking Our Industry by Storm

Today’s healthcare marketers have access to more digital health data than ever. We think of that data as oil and programmatic advertising as its engine, working together to supercharge pharma advertising campaign results.

With more advancements in data and measurement, CTV’s continued explosive growth, the ever-evolving privacy landscape, and the looming death of the third-party cookie, that car is only going to keep accelerating. We’re calling it now: 2023 will be a pivotal year for pharmaceutical advertising.

But how? We posed that question to top pharma and ad-tech industry leaders from DeepIntent, our clients, and our partners.

Complete the form to receive a copy of What We See for 2023: The Pharma Advertising Trends Taking Our Industry by Storm and get a glimpse into the future.

Our Partners

Share this Post

Related Articles

 In this episode, John Mangano sits down with Damon Basch, a leader in healthcare provider (HCP) marketing and VP, Strategic Partnerships at Veradigm. Damon shares his journey to becoming an expert in electronic health records (EHR) and clinical workflow communications. With insights from over a decade in the industry, he discusses the evolution of […]

 In this episode of Deep, John Mangano is joined by TelevisaUnivision’s Jorge Daboub (EVP, Client Partnerships — Pharma & Healthcare), an expert in health marketing to the Hispanic community. They dive into the often overlooked Hispanic market in pharma and healthcare, discussing the major gaps in media reach, data representation, and opportunities for growth. […]

 In this episode of Deep, John Mangano talks with Jason Patterson, Chief Analytics Officer at Publicis Health Media, about the evolving landscape of media, analytics, and advertising in healthcare. With a career spanning leadership roles in top media and analytics companies, Jason offers unique insights into how client expectations have transformed over the years […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.